Chongqing Lummy Pharmaceutical 483, Mar 2016

Chongqing Lummy Pharmaceutical 483, Mar 2016

Peter Baker FDA$119.00

FDA investigators audited the Chongqing Lummy Pharmaceutical facility in Chongqing, China and issued inspectional observations (via FDA 483) on 17 Mar 2016.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 17 Mar 2016
  • Location: Chongqing, China